Creative Planning’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Creative Planning’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,880	Closed	-$40K	–	2682
2021 Q1	$40K	Hold	17,880	–	–	﹤0.01%	2378
2020 Q4	$44K	Hold	17,880	–	–	﹤0.01%	2119
2020 Q3	$44K	Hold	17,880	–	–	﹤0.01%	1916
2020 Q2	$63K	Hold	17,880	–	–	﹤0.01%	1735
2020 Q1	$42K	Buy	+17,880	New	+$50.2K	﹤0.01%	1654
2015 Q4	–	Sell	-1,000	Closed	-$3K	–	4637
2015 Q3	$3K	Buy	+1,000	New	+$2.33K	﹤0.01%	3857
2015 Q2	–	Sell	-1,000	Closed	-$1K	–	3240
2015 Q1	$1K	Hold	1,000	–	–	﹤0.01%	4097
2014 Q4	$0	Hold	1,000	–	–	﹤0.01%	4392
2014 Q3	$4K	Hold	1,000	–	–	﹤0.01%	3427
2014 Q2	$5K	Hold	1,000	–	–	﹤0.01%	3250
2014 Q1	$5K	Hold	1,000	–	–	﹤0.01%	3111
2013 Q4	$6K	Hold	1,000	–	–	﹤0.01%	2790
2013 Q3	$7K	Hold	1,000	–	–	﹤0.01%	2628
2013 Q2	$5K	Buy	+1,000	New	+$5.07K	﹤0.01%	2571

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Creative Planning's NYMX Position: Q2 2021 in Review

Creative Planning sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 17,880 shares — an estimated $40K sold.

Creative Planning first reported a position in NYMX in Q2 2013 and held it in 14 quarters. The position peaked at $63K in Q2 2020. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

Creative Planning reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
Creative Planning sold 17,880 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $40K.
Creative Planning first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 14 quarters.
Creative Planning's Nymox Pharmaceutical Corp position peaked at $63K in Q2 2020.
51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.